Evidence map›Paper›PMID 30883881›Full record

ArticleProteins2019

Putative structural rearrangements associated with the interaction of macrocyclic inhibitors with norovirus 3CL protease.

Anushka C Galasiti Kankanamalage, Pathum M Weerawarna, Athri D Rathnayake, Yunjeong Kim, Nurjahan Mehzabeen, Kevin P Battaile, Scott Lovell, Kyeong-Ok Chang, William C Groutas

Abstract read
In one paragraph

Article in Proteins, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. PRSC chemical biology · 2023
    Review
  4. Structural similarities between SARS-CoV2 3CLFrontiers in chemistry · 2022
    Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Anushka C Galasiti KankanamalageDepartment of Chemistry, Wichita State University, Kansas.
Pathum M WeerawarnaDepartment of Chemistry, Wichita State University, Kansas.
Athri D RathnayakeDepartment of Chemistry, Wichita State University, Kansas.
Yunjeong KimDepartment of Diagnostic Medicine & Pathobiology, College of Veterinary Medicine, Kansas State University, Kansas.
Nurjahan MehzabeenProtein Structure Laboratory, The University of Kansas, Kansas.
Kevin P BattaileIMCA-CAT, Hauptman-Woodward Medical Research Institute, APS Argonne National Laboratory, Argonne, Illinois.
Scott LovellProtein Structure Laboratory, The University of Kansas, Kansas.
Kyeong-Ok ChangDepartment of Diagnostic Medicine & Pathobiology, College of Veterinary Medicine, Kansas State University, Kansas.
William C GroutasDepartment of Chemistry, Wichita State University, Kansas.ORCID 0000-0001-5248-7912

Funding

Small Molecule Protease Inhibitors against MERS-CoV and Coronaviruses of Pandemic PotentialR01AI130092 · NIAID · KANSAS STATE UNIVERSITY · PI Kyeong-Ok Chang, William Constantine Groutas · 2018 to 2026
$5.9M
Protein Structure Laboratory P30GM110761 · NIGMS · UNIVERSITY OF KANSAS LAWRENCE · PI HANZLIK, ROBERT P · 2014 to 2018
$5.6M
Norovirus 3CL Protease-Based Anti-norovirus TherapeuticsR01AI109039 · NIAID · KANSAS STATE UNIVERSITY · PI BOWLIN, TERRY L., CHANG, KYEONG-OK · 2014 to 2018
$3.7M
NIAID NIH HHS P30GM110761NIAID NIH HHS R01 AI109039NIAID NIH HHS R01 AI130092NIGMS NIH HHS P30 GM110761NIH HHS AI109039NIH HHS P30GM110761
6 · The paper itself

Abstract

Human noroviruses are the primary cause of outbreaks of acute gastroenteritis worldwide. The problem is further compounded by the current lack of norovirus-specific antivirals or vaccines. Noroviruses have a single-stranded, positive sense 7 to 8 kb RNA genome which encodes a polyprotein precursor that is processed by a virus-encoded 3C-like cysteine protease (NV 3CLpro) to generate at least six mature nonstructural proteins. Processing of the polyprotein is essential for virus replication, consequently, NV 3CLpro has emerged as an attractive target for the discovery of norovirus therapeutics and prophylactics. We have recently described the structure-based design of macrocyclic transition state inhibitors of NV 3CLpro. In order to gain insight and understanding into the interaction of macrocyclic inhibitors with the enzyme, as well as probe the effect of ring size on pharmacological activity and cellular permeability, additional macrocyclic inhibitors were synthesized and high resolution cocrystal structures determined. The results of our studies tentatively suggest that the macrocyclic scaffold may hamper optimal binding to the active site by impeding concerted cross-talk between the S

Indexed as

AnimalsCaliciviridae InfectionsCatalytic DomainCell LineCrystallography, X-RayCysteine ProteasesCysteine Proteinase InhibitorsGastroenteritisHumansMacrocyclic CompoundsMiceModels, MolecularNorovirusProtein ConformationRAW 264.7 CellsCysteine ProteasesCysteine Proteinase InhibitorsMacrocyclic Compoundsactive sitemacrocyclic inhibitorsnorovirus 3CL proteasestructural rearrangement

Identifiers

PMID30883881
PMCPMC6545144

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.